Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Used PM’s name in derogatory manner: Allahabad High Court refuses to quash case against Neha Singh Rathore

Ravish Kumar moves Delhi High Court against government order to remove content on Adani

Judges should be in love with justice and freedom, not money: CJI BR Gavai

Madhya Pradesh High Court orders action against woman for falsely accusing Senior Advocate of raping her daughter

Party autonomy in arbitration not absolute: Supreme Court Justice JK Maheshwari

SCROLL FOR NEXT